Education
About Us
Working with TipRanks
Follow Us
TC Biopharm (Holdings) (TCBPY)
OTHER OTC:TCBPY
TCBPY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.08 - $150.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)5.31K
Market Cap
$207.25K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,103,054
10 Day Avg. Volume1,910
30 Day Avg. Volume5,311
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TC Biopharm (Holdings) News
TCBPY FAQ
What was TC Biopharm (Holdings)’s price range in the past 12 months?
TC Biopharm (Holdings) lowest stock price was $0.08 and its highest was $150.88 in the past 12 months.
What is TC Biopharm (Holdings)’s market cap?
TC Biopharm (Holdings)’s market cap is $207.25K.
When is TC Biopharm (Holdings)’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TC Biopharm (Holdings)’s earnings last quarter?
Currently, no data Available
Is TC Biopharm (Holdings) overvalued?
According to Wall Street analysts TC Biopharm (Holdings)’s price is currently Overvalued.
Does TC Biopharm (Holdings) pay dividends?
TC Biopharm (Holdings) does not currently pay dividends.
What is TC Biopharm (Holdings)’s EPS estimate?
TC Biopharm (Holdings)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TC Biopharm (Holdings) have?
TC Biopharm (Holdings) has 2,103,054 shares outstanding.
What happened to TC Biopharm (Holdings)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TC Biopharm (Holdings)?
Currently, no hedge funds are holding shares in TCBPY
Company Description
TC Biopharm (Holdings)
TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) is a biotechnology company focused on developing innovative cell-based therapies for the treatment of cancer and other serious diseases. The company operates in the biopharmaceutical sector and is dedicated to leveraging its expertise in gamma-delta T cell technology to create effective immunotherapies. TC Biopharm's core products include novel therapies that aim to harness the body's immune system to target and eliminate cancer cells, providing patients with potentially transformative treatment options.
TC Biopharm (Holdings) (TCBPY) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Gilead Sciences
―
Bluebird Bio
―
Fate Therapeutics
―
Adaptimmune Therapeutics
―
Immatics
―